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During the “respiratory burst” in activated leukocytes, the
release of reactive oxygen species (ROS) and reactive nitro-
gen species (RNS) occurs, and these phenomes present a cen-
tral role in tissue repair [1, 2]. In the inflammatory phase,
neutrophils reach the injured area, sending signals for the
migration of macrophages that mediate the expression of
cytokines, growth factors, reactive oxygen (ROS), and nitro-
gen species (RNS) [3]. These ROS and RNS generated during
inflammation can lead to cell lesions such as membrane dis-
organization and protein oxidation by altering cellular func-
tions. The balance between ROS production and antioxidant
defense is important for efficient tissue repair in organs such
as the skin, liver, lungs, kidneys, heart, and testes [4–6].
When the tissue is damaged by reactive species, it is common
to observe lipid, protein, and DNA damage, leading to oxida-
tive stress that disables tissue repair [5, 6].
During the chronification process, a persistent activa-
tion of the COX way occurs, and neutrophils and macro-
phages release cytokines and chemokines, which attract
more cells to the location of the inflammation and promote
oxidative stress in the repairing tissue [7, 8]. The excess of
proinflammatory mediators promotes the increase of the
peroxide of hydrogen (H2O2) and nitric oxide content,
which accelerate the peroxidation of the component cells
[7, 8]. Therefore, a controlled inflammation process is nec-
essary to avoid persistent tissue damage through the con-
tinued action of free radicals and reactive oxygen species
(ROS) [7]. Associated with this, we can highlight that the
healing environment is usually prooxidant and generally
presents a decrease in the synthesis and expression of anti-
oxidant enzymes such as superoxide, glutathione, and cata-
lase, impairing the healing environment [8, 9]. In general, a
desirable repairing process results from the balance between
the synthesis and degradation of inflammatory mediators
and pro- and antioxidant compounds [9, 10].
Antioxidant systems seem to play a crucial role in main-
taining the morphological and functional integrity of all
microorganisms. Accordingly, disruptors of redox balance
(e.g., inductors of oxidative stress or inhibitors of antioxidant
molecules) have been proposed as candidates for new healing
drugs. Ideally, modulators of redox systems should be able to
influence fibroblast migration, proliferation, increased colla-
gen synthesis, and scar tensile strength, a process partially
mediated by ROS and RNS catalysis [11, 12]. Interestingly,
several drugs and compounds developed for different condi-
tions (e.g., NLRP3, propolis, carbon monoxide, tea polysac-
charides, safflor yellow B, radiation, Huangbai liniment,
lipoxin A4 ameliorates, resveratrol, and MiR-200c) exhibit
antioxidant, anti-inflammatory, and antimicrobial proper-
ties. In many cases, these properties are based on the
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disruption of cell redox metabolism, a pharmacological effect
that opens new venues for drug repurposing and the develop-
ment of new strategies for the treatment of tissue injury.
This special issue gathers a set of 17 studies in an interdis-
ciplinary platform that addresses the subcellular, cellular, and
molecular bases of the metabolism redox associated with the
recovery of damaged tissue. This special issue also highlights
the continuing effort to understand the redox systems associ-
ated with repairing tissues in all levels and understand how
the action of different treatments can lead to the increase of
antioxidant enzyme levels, such as superoxide dismutase
(SOD), catalase (CAT), and glutathione peroxidase (GPx),
and consequently accelerate the healing process in different
tissues. This issue contains seventeen papers describing dif-
ferent mechanisms involved in tissue repairing in different
pathological conditions, which are briefly mentioned below.
Some studies have shown that external agents like alco-
hol, carbon monoxide, cadmium, and radiation exposition
reflect an imbalance between oxidants and antioxidant
mechanisms in favour of oxidants capable of provoking tis-
sue damage. These prooxidant mechanisms are related to
genetic and epigenetic regulation and can regulate the
expression of molecules that can activate signal transduction
pathways responsible for inflammation and cause oxidative
damage to proteins, lipids, and DNA. The studies in this issue
showed that the redox system begins producing free radicals
a few hours after exposure and can upregulate several
enzymes including nicotinamide adenine dinucleotide phos-
phate oxidase (NADPH oxidase), lipoxygenases (LOXs),
nitric oxide synthase (NOS), and cyclooxygenase (COXs).
These enzymes are expressed in specific ways in various cells,
tissues, and organs. Normal cells that are exposed to these
external agents will give rise to nuclear and mitochondrial
DNA damage, which can lead to cell death via processes such
as apoptosis and necrosis. Necrosis can trigger the release of
inflammatory cytokines such as IL-1, IL-4, IL-13, and other
inflammatory mediators, while apoptosis may cause the
release of anti-inflammatory cytokines including TGF-β
and IL-10.
Considering the development of new drugs and treat-
ments, the studies published in this edition were very broad
and addressed different types of therapies in the treatment
of injuries in various systems. The use of natural products
obtained from plants and animals were more common;
among them, we can highlight propolis-nanofiber dressing
used for burn treatment and the Huangbai liniment plant
compost for accelerated wound healing by Nrf2 activation
signalled in diabetes. In one study, Danhong injection was
extracted from Salviae Miltiorrhizae Radix and Carthami
tinctorii Flos and showed several positive effects, such as
anti-inflammatory, antioxidant, and antiapoptotic, and pre-
vented postoperative adhesion. In another study, resveratrol
showed protection against thioacetamide toxicity in rat kid-
neys with respect to DNA damage, oxidative stress, renal
function, and cytokine release.
In addition, two studies analysed the importance of nutri-
tion for oxidative stress in tissues. The former study showed
that nutrient intake and malnutrition can act as predictors of
oxidative uremic toxicity. Therefore, they provided evidence
that age and sex exhibited a limited association with malnu-
trition and cardiometabolic risk factors in haemodialysis
patients. In addition, these authors showed that serum anti-
oxidant mediators seem to have greater predictive sensitivity
to estimate molecular oxidative damage in haemodialysis
patients. The latter study evaluated glutamine supplementa-
tion for the treatment of acute pancreatitis and showed that
the use of glutamine might be promising for the future man-
agement of acute pancreatitis by relieving the intracellular
energy stress, thereby attenuating the predominance of
necrosis over apoptosis. Moreover, one review summarized
the role of macroautophagy in the heart following myocar-
dial infarction and showed that some noncoding RNAs and
their easy manipulation exposed their potential as new
targets for clinical development to treat autophagy-related
diseases. Identification of specific cardiac noncoding RNAs
that regulate autophagy could be a good opportunity to pro-
tect the heart from myocardial infarction injury without
affecting the autophagy activity in other organs.
We hope that the readers of this special issue will find
these findings interesting and useful to advance the under-
standing of such a complex and multifaceted theme, suggest-
ing an update for this interesting topic.
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